◆英語タイトル：University of Rochester - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA8013504
◆発行会社（調査会社）：
GlobalData
◆発行日：2017年11月28日
◆ページ数：29
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
Summary
University of Rochester (UOR) is an educational university that offers research and development services. The university performs research in the areas of humanities, engineering medical education, medicine, geology, optics, economics, political theory, human behavior, and social and natural sciences. It offers various programs such as actuarial studies, American Sign Language, American studies, anthropology, applied mathematics, Arabic minor, art history, biological sciences, computational biology, and biotechnology, among others. The university owns and maintains Eastman School of Music, School of Medicine and Dentistry, School of Nursing, School of Arts and Sciences, Hajim School of Engineering and Applied Sciences, Simon Business School and Warner School of Education. UOR is headquartered in Rochester, New York, the US.
University of Rochester – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Rochester, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Rochester, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Rochester, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Rochester, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Rochester, Medical Devices Deals, 2011 to YTD 2017 9
University of Rochester, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Rochester, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
University of Rochester Medical To Acquire Certain Assets From Lakeside Health System 11
Partnerships 12
Taithera Plans to Enter into Distribution Agreement with University of Rochester for Bone-Targeted Therapeutic Agent 12
University of Rochester Medical Center Partners with Indivumed 13
Qu Biologics Enters into Research Agreement with University of Rochester 14
University Of Rochester Medical Enters Into Co-Development Agreement With Temple University 15
Licensing Agreements 16
Vivione Biosciences Enters into Licensing Agreement with University of Rochester 16
Panther Biotech Enters into Licensing Agreement with University of Rochester 17
MiniVax Enters Into Option For Licensing Agreement With University of Rochester 18
Acquisition 19
University of Rochester Medical To Acquire Thompson Health 19
University of Rochester – Key Competitors 20
University of Rochester – Key Employees 21
University of Rochester – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Government and Public Interest 23
Nov 16, 2017: Telephus Medical Founder Awarded $6 Million NIH Grant to Expand Translational Research in Bone Infections 23
Jul 26, 2017: Gene Therapy to Correct Surfactant Protein B Deficiency in Newborns 24
Jul 26, 2017: University of Rochester Awarded $19 Million to Coordinate National Clinical and Translational Science Program 25
Mar 02, 2016: Researchers Funded by National MS Society Pinpoint Direct Damage to Nerve Connections in Mice, Independent of Myelin Damage 27
Other Significant Developments 28
Aug 16, 2017: Radiation Oncology begins Metastatic Cancer & Palliative Care service 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Tables
University of Rochester, Pharmaceuticals & Healthcare, Key Facts 2
University of Rochester, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Rochester, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Rochester, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Rochester, Deals By Therapy Area, 2011 to YTD 2017 8
University of Rochester, Medical Devices Deals, 2011 to YTD 2017 9
University of Rochester, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Rochester Medical To Acquire Certain Assets From Lakeside Health System 11
Taithera Plans to Enter into Distribution Agreement with University of Rochester for Bone-Targeted Therapeutic Agent 12
University of Rochester Medical Center Partners with Indivumed 13
Qu Biologics Enters into Research Agreement with University of Rochester 14
University Of Rochester Medical Enters Into Co-Development Agreement With Temple University 15
Vivione Biosciences Enters into Licensing Agreement with University of Rochester 16
Panther Biotech Enters into Licensing Agreement with University of Rochester 17
MiniVax Enters Into Option For Licensing Agreement With University of Rochester 18
University of Rochester Medical To Acquire Thompson Health 19
University of Rochester, Key Competitors 20
University of Rochester, Key Employees 21
University of Rochester, Other Locations 22
University of Rochester, Subsidiaries 22
